Abstract:Background: Cardiovascular-Kidney-metabolic (CKM) syndrome is a public health problem involving > 90% of the US and results in premature CVD at a relatively preserved GFR. The molecular mediators of CKM are poorly understood, partly due to the lack of a reliable animal model. We set out to generate an animal model with renal and metabolic dysfunctions, using PAD as a CKM manifestation. Methods: A group of C57BL/6 mice was randomized into four groups- a normal diet (ND), a 0.2% adenine diet (AD, a CKD model), a high-fat diet (HFD, a metabolic model), and a combination of HFD+AD (a potential CKM model). Mice underwent a hind limb ischemia surgery. An array of structural (capillary density, soleus muscle evaluation), and functional assays were performed. Results: Compared to ND mice, AD mice showed loss of weight (40%) and GFR (90%) (P<0.001). The HFD+AD mice had 23-50% higher weight and GFR than the AD group (P = 0.003). The kidneys of HFD+AD showed tubular atrophy, tubulointerstitial fibrosis, immune infiltration, glomerulomegaly, consistent with glomerular hyperperfusion, hypercholesterolemia, impaired glucose tolerance, and adipophilin in the liver, an early marker of hepatic steatosis, and myocardial fibrosis. Compared to ND mice, the AD and HFD+AD mice showed similar reductions in the hind limb perfusion ratios, microcapillary density, Type II muscle fibers, and increased muscle fibrosis, immune infiltration, and lowest cross-sectional muscle area. Compared to AD, HFD+AD mice showed a lower flux ratio and grip strength, all at a GFR double that of the AD group. Conclusion: A combination of HFD+AD in mice displays features of CKD (loss of GFR, renal fibrosis), dysfunctional obesity (dyslipidemia, impaired glucose tolerance, hepatic steatosis and glomerulomegaly), and cardiovascular disease (myocardial fibrosis and PAD) at a higher GFR, consistent with the features of CKM. This model can be explored to probe the mechanisms of CKM syndrome.

Murine Models of Myocardial and Limb Ischemia: Diagnostic End-Points and Relevance to Clinical Problems

Murine Models of Vascular Endothelial Injury: Techniques and Pathophysiology

Small Mammalian Animal Models of Heart Disease.

Animal Models of Ischemic Heart Disease for in Vivo Cardiac MR Imaging Research

A Minimally Invasive Approach to Induce Myocardial Infarction in Mice Without Thoracotomy

Large Mammalian Animal Models of Heart Disease

Inflammation and fibrosis in murine models of heart failure

Current Status and Limitations of Myocardial Infarction Large Animal Models in Cardiovascular Translational Research

Preclinical Large Animal Porcine Models for Cardiac Regeneration and Its Clinical Translation: Role of hiPSC-Derived Cardiomyocytes

Animal Models for Cardiovascular Research

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy

Application of Animal Models in Diabetic Cardiomyopathy

Animal Models of Cardiac Disease and Stem Cell Therapy.

Considerations for the Bioengineering of Advanced Cardiac In Vitro Models of Myocardial Infarction

Multiparametric Immunoimaging Maps Inflammatory Signatures in Murine Myocardial Infarction Models

Methodology for the induction of myocardial infarction and cardiac function evaluation

Myocardial Ischemia-Reperfusion and Diabetes: Lessons Learned From Bedside to Bench

Intracardiac electrophysiology to characterize susceptibility to ventricular arrhythmias in murine models

Animal experimental models of ischemic wounds – A review of literature

A murine model of cardiovascular-kidney-metabolic syndrome demonstrates compromised limb function in the ischemic hind limb

Mouse models of arteriosclerosis: from arterial injuries to vascular grafts.